These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells. Sakuma N; Kamei T; Ishihara T Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130 [TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma: ultrastructural distinction from adenocarcinoma. Warhol MJ; Hickey WF; Corson JM Am J Surg Pathol; 1982 Jun; 6(4):307-14. PubMed ID: 6287872 [TBL] [Abstract][Full Text] [Related]
6. The distinction of mesothelioma from adenocarcinoma in malignant effusions by electron microscopy. Kobzik L; Antman KH; Warhol MJ Acta Cytol; 1985; 29(3):219-25. PubMed ID: 3859121 [TBL] [Abstract][Full Text] [Related]
7. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. Dewar A; Valente M; Ring NP; Corrin B J Pathol; 1987 Aug; 152(4):309-16. PubMed ID: 3668733 [TBL] [Abstract][Full Text] [Related]
8. [Differential diagnosis among reactive mesothelia, adenocarcinoma and malignant mesothelioma]. Kamei T; Sakuma N Rinsho Byori; 1999 Jul; 47(7):601-13. PubMed ID: 10442038 [TBL] [Abstract][Full Text] [Related]
9. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Lee I; Radosevich JA; Chejfec G; Ma YX; Warren WH; Rosen ST; Gould VE Am J Pathol; 1986 Jun; 123(3):497-507. PubMed ID: 3717302 [TBL] [Abstract][Full Text] [Related]
10. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
11. Scanning electron microscopic distinction of pleural mesotheliomas from adenocarcinomas. Jandik WR; Landas SK; Bray CK; Lager DJ Mod Pathol; 1993 Nov; 6(6):761-4. PubMed ID: 8302820 [TBL] [Abstract][Full Text] [Related]
12. Cytopathology of malignant mesothelioma of the pleura in fine-needle aspiration biopsy. Nguyen GK; Akin MR; Villanueva RR; Slatnik J Diagn Cytopathol; 1999 Oct; 21(4):253-9. PubMed ID: 10495318 [TBL] [Abstract][Full Text] [Related]
13. Ultrastructural studies of malignant cells in fluids. Herrera GA; Wilkerson JA Diagn Cytopathol; 1985; 1(4):272-85. PubMed ID: 3013534 [TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Gaffey MJ; Mills SE; Swanson PE; Zarbo RJ; Shah AR; Wick MR Am J Surg Pathol; 1992 Jun; 16(6):593-9. PubMed ID: 1599037 [TBL] [Abstract][Full Text] [Related]
16. A novel biotinylated probe specific for hyaluronate. Its diagnostic value in diffuse malignant mesothelioma. Azumi N; Underhill CB; Kagan E; Sheibani K Am J Surg Pathol; 1992 Feb; 16(2):116-21. PubMed ID: 1733346 [TBL] [Abstract][Full Text] [Related]
17. Distinguishing malignant mesothelioma from pulmonary adenocarcinoma: an immuno-histochemical approach using a panel of monoclonal antibodies. Tuttle SE; Lucas JG; Bucci DM; Schlom J; Primus J J Surg Oncol; 1990 Oct; 45(2):72-8. PubMed ID: 2214794 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Otis CN; Carter D; Cole S; Battifora H Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954 [TBL] [Abstract][Full Text] [Related]
19. An intriguing case: malignant mesothelioma presenting as inguinal lymph node metastases. King JA; Listinsky CM; Tucker JA Ultrastruct Pathol; 2004; 28(2):109-13. PubMed ID: 15205111 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of membranous staining of mesothelioma. King JA; Tucker JA Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]